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Abstract
Background: Chikungunya Virus (ChikV) surprised by a massive re-emerging outbreak in Indian Ocean in 2006,
reaching Europe in 2007 and exhibited exceptional severe physiopathology in infants and elderly patients. In this
context, it is important to analyze the innate immune host responses triggered against ChikV. Autophagy has been
shown to be an important component of the innate immune response and is involved in host defense elimination
of different pathogens. However, the autophagic process was recently observed to be hijacked by virus for their
own replication. Here we provide the first evidence that hallmarks of autophagy are specifically found in HEK.293
infected cells and are involved in ChikV replication.
Methods: To test the capacity of ChikV to mobilize the autophagic machinery, we performed fluorescence
microscopy experiments on HEK.GFP.LC3 stable cells, and followed the LC3 distribution during the time course of
ChikV infection. To confirm this, we performed electron microscopy on HEK.293 infected cells. To test the effect of
ChikV-induced-autophagy on viral replication, we blocked the autophagic process, either by pharmacological (3-
MA) or genetic inhibition (siRNA against the transcript of Beclin 1, an autophagic protein), and analyzed the
percentage of infected cells and the viral RNA load released in the supernatant. Moreover, the effect of induction
of autophagy by Rapamycin on viral replication was tested.
Results: The increasing number of GFP-LC3 positive cells with a punctate staining together with the enhanced
number of GFP-LC3 dots per cell showed that ChikV triggered an autophagic process in HEK.293 infected cells.
Those results were confirmed by electron microscopy analysis since numerous membrane-bound vacuoles
characteristic of autophagosomes were observed in infected cells. Moreover, we found that inhibition of
autophagy, either by biochemical reagent and RNA interference, dramatically decreases ChikV replication.
Conclusions: Taken together, our results suggest that autophagy may play a promoting role in ChikV replication.
Investigating in details the relationship between autophagy and viral replication will greatly improve our
knowledge of the pathogenesis of ChikV and provide insight for the design of candidate antiviral therapeutics.
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Background
Chikungunya Virus (ChikV) is an Alphavirus of the
Togaviridae family transmitted to humans through
arthropods bites (mosquitoes of the Aedes genus). First
described during a Tanzanian outbreak in 1952 [1],
ChikV was recently responsible for a massive re-
emerging outbreak in a large tropical area (East Africa
and Indian Ocean in 2006, India, Thailand and Indone-
sia in 2007) and a limited epidemic in Italy in 2007. In
2005-2006, the virus has reached Reunion Island, a
south French territory, with an estimated 270 000 cases
(1/3
rd of the population) and severe forms of the dis-
ease, like encephalopathy, in a context of arthralgia,
rash, headache and a strong lymphopenia were reported.
This 12 Kb positive-strand RNA virus contains two
open reading frames (ORFs). The 5’ ORF, for the viral
replication complex, encodes the non-structural
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proteins, encodes for the capsid, envelope glycoproteins
(E1 and E2), E3 and 6k proteins. Interestingly, infection
with positive-strand RNA viruses may result in the rear-
rangement of intracellular membranes, constituting scaf-
folds for viral genome replication [2].
Macro-autophagy, referred herein to autophagy, is a
fundamental homeostatic process that leads to the
degradation and recycling of long-lived proteins and
organelles [3,4]. The molecular machinery of autophagy
was identified in yeast by genetic screening with the
d i s c o v e r yo f3 0A u T o p h a G y - r e l a t e dg e n e s( A T G )[ 5 ] .
Most of these genes have now been identified in other
organisms as orthologs, suggesting that autophagy is a
highly conserved mechanism in eukaryotes [6]. The
hallmark of autophagy is the formation of double or
multiple membrane-bound vesicles called autophago-
somes, which sequester a portion of the cytoplasm and
fuse, after maturation, with lysosomes to digest their
contents. Formation of the autophagosome requires
two ubiquitin-like systems: a conjugate of Atg5-Atg12
and a conjugate in which microtubule-associated pro-
tein light chain 3, LC3, is cleaved to produce LC3-I
and LC3-II. Autophagy is first a fundamental cell sur-
viving process during starvation conditions but also
participates in various proc e s s e ss u c ha sd e v e l o p m e n t
and tumor suppression [7]. Futhermore, autophagy
plays a role in both innate and adaptive immunity in
response to pathogens [8]. Indeed, the antiviral action
of autophagy has been characterized in infection by
sindbis virus, tobacco mosaic virus, vesicular stomatitis
virus, herpes simplex virus type 1 and the DNA virus
parvovirus B19 [9-11]. In contrast, some viruses have
evolved strategies to interfere, escape or even exploit
the autophagic machinery. This is the case for certain
positive-stranded RNA viruses, such as coronaviruses,
picornaviruses, murine hepatitis virus, equine arteri-
virus, coxsackievirus, hepatitis C virus and dengue
virus, which use the autophagosomal machinery to
facilitate the assembly of RNA replication complexes
[12-15]. More recently, Rodriguez-Rocha et al. found
that autophagy-induced in adenovirus infection pro-
motes viral infection and oncolysis [16]. Here,
we explore the role of the autophagy machinery in
ChikV-infected cells by monitoring the presence
of double-membrane vesicles and the distribution of
LC3. As well, we demonstrate the effects of perturbing
the autophagy pathway, using pharmacological inhibi-
tors or RNA interference, on viral replication. The pre-
sent study provides the first evidence that cellular
autophagy is promoted in ChikV-infected cells and
contributes to enhance ChikV replication.
Materials and methods
Cells and culture conditions
The HEK.293 cell lines were maintained at 37°C in an
humidified atmosphere containing 5% CO2 in complete
medium (Dulbecco’s modified Eagle’s medium) supple-
mented with 10% heat inactivated fetal calf serum
together with penicillin (100 μg/ml), streptomycin (100
U/ml), sodium pyruvate (1 mM), L-glutamine (5 mM)
and fungizone (0.5 μg/ml) available from Dutscher (Bru-
math, France). HEK.293 cells constitutively expressing a
GFP-LC3 transgene were generated by transfection of
the GFP-LC3 plasmid (kindly provided by M. Biard-Pie-
chaczyk, Montpellier, France). Transfected cells were
initially selected with 400 μg / m lo fG 4 1 8a n dk e p tf o r
maintenance with 40 μg/ml of G418.
Viral stock and inhibition/activation assays
We used a viral isolate (ChikV clone #4) amplified from
ap a t i e n t ’s serum sample isolated during the 2006 epi-
demic [17]. One step qRT-PCR was used to amplify the
E1 gene.
In infection experiments, biochemical reagents (inhibi-
tor or activator) were added two hours before infection
with ChikV (MOI = 1) and samples were analyzed at 24
h and 48 h post-infection.
Primers used for RT-PCR
The following primers were used:
Hu GAPDH_F, 5’-GAACGGGAAGCTTGTCATCA-3’
(position 291-310), and Hu GAPDH_R, 5’-TGACCTT
GCCCACAGCCTTG-3’ (position 744 -763); sequence
reference NM_002046; amplicon 473 bp.
CHIK E1_F, 5’-AAGCTYCGCGTCCTTTACCAAG-3’
(position 10387-10400), and CHIK E1_R, 5’ -CCAAATT
GTCCYGGTCTTCCT-3’ (position 10595-10575);
sequence reference EU-037962.1; amplicon 209 bp.
Reagents and antibodies
Rapamycin, an autophagy inducer, was purchased from
Sigma, and used at a 1 μM final concentration. 3-Methyl-
Adenine, an autophagy inhibitor, was purchased from
Sigma, and used at a 10 mM final concentration. Beclin-1
small interfering RNA (siRNA) was purchased from
Eurogentec. FDO anti-serum was obtained from a patient
with acute Chikungunya, described in (Krejbich-Trotot,
et al. 2011 [18]). Monoclonal mouse anti-ChikV antibo-
dies (clones 6C and 4F), a kind gift from Biomerieux,
Marcy l’Etoile, France, and IMTSSA (Armed Forces Insti-
tute of Tropical Medicine, Pharo), Marseille, France, were
used to detect ChikV. The GFP-LC3 plasmid was kindly
provided by Martine Biard-Piechaczyk. Anti-Beclin and
anti-Actin antibodies were purchased from Sigma.
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Adherent cells were grown and infected on glass cover-
slips, fixed and permeabilized at different times post
infection by immersion in frozen ethanol for 5 min and
c o n s e r v e da t-2 0 ° C .C o v e r s l i p sw e r ei n c u b a t e di np r i -
mary antibodies (1/200) in PBS-BSA 1% and then with
secondary antibody conjugated to Alexa594 (1/1000).
Nucleus morphology was revealed by DAPI staining
(final concentration: 100 ng/ml). Coverslips were
mounted in Vectashield H-1000 (Vectorlabs, Clinis-
ciences) and fluorescence was observed using a Nikon
Eclipse E2000-U microscope. Images were obtained
using the Nikon Digital sight PS-U1 camera system and
the imaging software NIS-Element AR.
Electron micrographs of ChikV-infected HEK.293 cells
Cells infected with Chikungunya virus at MOI = 5 were
processed for electron microscopy as described in [19].
Western blotting
Cells were harvested with a scraper and resuspended in
lysis buffer (PBS1X, TritonX100 1%, EDTA 1 mM con-
taining a cocktail of protease inhibitors: PMSF, pepstatin
A, leupeptin, aprotinin all at 1 μg/ml final concentra-
tion). Protein extracts were mixed with one volume of
loading buffer (Tris 0,1 M, Glycerol 10%, SDS 2%)
according to Laemmli’s protocol. About 50 μg of each
sample was loaded onto a 4-12% precasted NuPAGE
gels (Invitrogen). After electrophoretic migration, pro-
teins were electrotransferred onto a nitrocellulose mem-
brane (Millipore). Membranes were incubated with
primary antibodies and followed by horseradish peroxy-
dase-conjugated secondary antibody. After further
washes, the immune complexes were revealed by ECL
(PerkinElmer).
RNA Interference
Cells were grown to 50% to 80% confluence and transi-
ently transfected with an annealed beclin-1 siRNA using
FuGEN HD (Roche) according to the manufacter’s
intructions. An aspecific (unrelated) siRNA was used as
a negative control. The silencing efficiency was assessed
by Western Blot analyses of whole cell extract using an
anti-Beclin-1 antibody. The sense oligonucleotide speci-
fic for Beclin-1 was: 5’-CAGUUUGGCACAAUCAAUA-
3’.
Statistics
All values are expressed as means +/- sd and as percen-
tages of 3 independent experiments, each using triplicate
culture plates. Comparisons between different treatment
regimes have been analyzed by the Mann-Whitney exact
test (Graph-Pad, San Diego, CA, USA). Degrees of
significance are indicated in the figure captions as
follow: * p < 0.05; ** p < 0.01; *** p < 0.001.
Results
HEK.293 cells are susceptible to infection by ChikV
HEK.293 cells were challenged with a multiplicity of
infection (MOI) of 1 of the ChikV clone #4 to evaluate
their susceptibility to the virus and their ability to pro-
duce viral progeny. Susceptibility to ChikV was next
determined by mean of immunofluorescence detection
of E1 envelope glycoprotein (Figure 1A). Figure 1B
shows the percentage of ChikV-infected cells during the
time course of infection. At MOI = 1, ChikV antigen E1
was detected on few percentage of cells (1.6% +/- 0.65)
as early as 8 hours after infection. About 35% (+/-11%)
of the cells were replicating the virus within the first 24
h and about 84% (+/-12%) of the cells were ChikV posi-
tive 48 hours post infection. Release of ChikV particles
in culture supernatant was monitored by quantification
of viral RNA using qRT-PCR (Figure 1C). At 48 h post
infection, almost 1.2 × 10
10/ml viral RNA copies were
detected from the cell culture supernatant. These data
confirm that HEK.293 cells are susceptible to ChikV
and efficiently replicate the virus, as previously reported
[20,21].
Chikungunya virus induces autophagy in HEK.293 cells
Two forms of LC3 have been reported in the literature.
In absence of autophagy, LC3 adopts a diffuse cytoplas-
mic localization pattern. When autophagy is stimulated,
LC3 is conjugated to phosphatidylethanolamine, which
participates in the formation of autophagosomes and
remains on the autophagosomes membranes [22].
Therefore, modification of LC3 distribution from a dif-
fuse to a punctate staining has been suggested to be a
hallmark of autophagy. To decipher the relationship
between ChikV and autophagy, we performed fluores-
cence microscopy experiments in order to follow the
LC3 distribution during the time course of ChikV infec-
tion. To this end, we generated from HEK.293 cells a
stable cell line that expresses the fusion protein of green
fluorescent protein (GFP) and LC3. In uninfected cells
(Ct), GFP-LC3 showed a diffuse localization throughout
the cytoplasm (Figure 2A). During the time course of
ChikV infection, GFP-LC3 adopts a punctate staining
(number of GFP-LC3 dots per cell in Control: 2.3
+/-1.2; 16 h post infection: 25.9+/-4.9; 48 h post infec-
tion: 38.2 +/- 2.8). We showed that both the number of
GFP-LC3-HEK.293 cells with punctate GFP-LC3 stain-
ing (Figure 2B) and the number of GFP-LC3 dots per
cell (Figure 2C) were highly increased. These results
indicate that ChikV infection generates a redistribution
of LC3 and stimulates autophagy.
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HEK.293 cells
To confirm that ChikV infection triggers an autophagic
process in target cells, we performed an ultrastructure
analysis of ChikV-infected HEK.293 cells using transmis-
sion electron microscopy (TEM). The cells were chal-
lenged with a high infectious dose of ChikV (MOI = 5)
to increase the number of infected cells in the culture
and favor the visualization of ChikV-positive cells and
processed for electron microscopy. In these cells, we
observed numerous membrane-bound vacuoles charac-
teristic of autophagosomes (Figure 3A and 3B) that were
not present when the HEK.293 cells were mock infected
(data not shown). Therefore, this observation confirms
that ChikV infection stimulates autophagosome forma-
tion in HEK.293 cells. Interestingly, a proportion of vir-
ions were observed within the lumen of double-
membrane-vesicles (Figure 3C) and we observed a sig-
nificant proportion of cells that contained assembled
bona fide viral particles. The colocalisation of viral parti-
cles in these structures suggests that they may interfere
with the viral life cycle.
Impairment of autophagy reduces ChikV replication
To determine whether the autophagic process induced
during ChikV infection was a host antiviral response or
a proviral replication mechanism, we tested the effect of
3-Methyladenine (3-MA) on ChikV replication. 3-MA is
a widely used selective inhibitor of autophagy which
blocks the formation of autophagosomes and inhibits
intracellular protein degradation without affecting pro-
tein synthesis [23]. Pre-treatment with 3-MA 2 hours
before the infection with ChikV (MOI = 1) resulted in a
significant reduction in the number of ChikV infected
cells as shown by immunofluorescence microscopy (Fig-
ure 4A and 4B). ChikV viral RNA release in culture
supernatant was also significantly reduced (Figure 4C).
Furthermore, Western Blot analysis showed a limited
Figure 1 HEK.293 cells are susceptible to infection by ChikV. HEK.293 cells cultured on glass coverslips were incubated from 8 h to 48 h
with a MOI = 1 of the ChikV or mock infected. (A) ChikV infection was monitored by immunofluorescence microscopy 48 h post infection by
detection of viral antigens using anti-E1 monoclonal antibody and Alexa Fluor 594-conjugated secondary reagents. Nuclei were stained with
DAPI. Magnification = 200× (B) The percentage of ChikV-infected cells was quantified during the time course of infection (at least 100 DAPI-
stained cells were counted in four separate fields). (C) RNA copy number in culture supernatant was determined by qRT-PCR amplification of the
E1 gene. A serial dilution of an E1 plasmid was used as a standard. Values are expressed as the mean of five independent experiments +/-
standard deviations.
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Page 4 of 10Figure 2 Redistribution of GFP-LC3 autophagy marker in ChikV-infected HEK.293 cells. (A) GFP-LC3-HEK.293 stable cells cultured on glass
coverslips were incubated from 2 h to 48 h with ChikV (MOI = 1) or mock infected (Ct) and analysed by fluorescence microscopy to determine
GFP-LC3 distribution. The status of cells regarding infection was determined by detection of ChikV antigens using a monoclonal antibody
directed against the E1 glycoprotein and Alexa Fluor 594 (red)-conjugated secondary reagent. Nuclei were stained with DAPI. Magnification =
200× (upper panel), magnification = 600× (lower panel) (B) GFP-LC3 positive cells were defined as cells that display more than 5 dots in the
cytoplasm. Numbers of GFP-LC3 positive cells were counted on more than 100 cells. (C) For each positive cell, the number of GFP-LC3 dots was
counted. These results are expressed as mean values obtained from three independent experiments +/- standard errors.
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infected cells pre-incubated with 3-MA (Figure 4D).
This finding suggests that the autophagic machinery
may not have an antiviral role during ChikV infection
and instead may favor ChikV replication.
To confirm the observation observed with pharmaco-
logical inhibitors, we used a target-specific RNA inter-
ference approach which will disrupt the autophagosomal
machinery. Cells were transfected with siRNA to knock
down beclin-1 gene expression. As shown in Figure 4E,
cells transfected with specific siRNA reducing cellular
Beclin-1 expression poorly supported ChikV replication
unlike the unrelated siRNA-treated cells. These results
further demonstrate that autophagy is required for effec-
tive ChikV replication and enhances an intracellular step
of the virus life cycle that remains to be elucidated.
Induction of autophagy enhances viral growth
T of u r t h e rd e t e r m i n et h er o l eo fa u t o p h a g yi nv i r a l
replication, we investigated the effect of autophagy
induction on viral protein expression. Cells were trea-
ted with the pharmacological reagent Rapamycin,
which has been shown to induce autophagy through
inhibition of the mTOR pathway. We observed that
pre-treatment with Rapamycin 2 hours before infection
with ChikV significantly increased the number of
infected cells detected by immunofluorescence detec-
tion of E1 glycoprotein (Figure 5A and 5B). Levels of
ChikV viral RNA detected in the cell culture superna-
tant were also increased when cells were treated with
Rapamycin (Figure 5C). Furthermore, Western Blot
analysis showed that expression of E1 and E2 envelope
glycoproteins and capsid protein is enhanced in cells
exposed to the drug before viral challenge (Figure 5D).
Although we can not totally rule out off-target effects
of drugs on processes distinctf r o ma u t o p h a g yr e q u i r e d
for viral replication, these results further suggest that
the autophagic process enhances viral replication and
that it is critical for an intracellular step of the virus
life cycle.
Figure 3 Electron micrographs of CHIKV-infected HEK.293 cells. (A) Cells infected with ChikV at MOI = 5 were processed for electron
microscopy. Infected cells presented an accumulation of membranous vesicles with clear content reminiscent of autophagosomes. A very large
vesicle located near the nucleus (see enlargement in B) contained degradated material. Smooth reticulum surrounding the vacuole is indicated
by arrows. The presence of bona fide viral particles with diameters of 40 nm and containing electron dense material detected inside this
autophagosome are indicated in C.
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Page 6 of 10Figure 4 Effects of autophagic blockade on ChikV infection. (A) HEK.293 cells were pretreated with the inhibitor of autophagy 3-MA
(10 mM) for 2 hours or left untreated (Ct). Then, the cells were infected by ChikV at a MOI = 1, as described in Materials and Methods. ChikV
infected cells were visualized by immufluorescence, using a monoclonal antibody directed against E1 glycoprotein. Magnification = 200× (B)
Quantitative analysis of ChikV expression in cells treated or not with 3-MA. (C) Consequences of 3-MA treatment on viral particle release. Viral
RNA level was determined from cell supernatant. Values are expressed as fold change relative to levels detected from untreated cells. (D)
Intracellular expression of ChikV structural proteins in HEK.293 maintained in medium alone or supplemented by 10 mM of 3-MA was detected
by Western blot. (E) HEK.293 cells were infected by ChikV with a MOI = 1 after transfection with Beclin-1 or unrelated siRNA. Expression of
Beclin-1 was monitored by immunoblotting using a specific mAb directed against Beclin-1. Quantitative analysis of the viral RNA in cell culture
supernatant was determined 24 h post infection. Results are represented as mean values from three independent experiments with standard
errors. * P < 0.05; ** P < 0.01; *** P < 0.001.
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In addition to the proteasomal degradation, autophagy
represents a major catabolic pathway allowing the turn-
over of cytoplasmic constituents in eukaryotic cells.
Besides this house-keeping role, autophagy is now consid-
ered as a central component of the host immune antimi-
crobial response against intracellular pathogens. Indeed,
certain pathogens, like bacteria, parasites and virus, have
been shown to be targeted for autophagic degradation.
Therefore some intracellular pathogens have evolved to
counteract host autophagy. Three main types of interac-
tion have been described in the literature between autop-
hagy and viruses. (1) Autophagy may have a protective
role by limiting virus replication. It has been shown for
tobacco mosaic virus, Sindbis virus and parvovirus B19
[9-11]. (2) Autophagic machinery may be disrupted by
some viruses. This is the case for herpes simplex virus
(HSV-1) which encodes the ICP34.5 protein implicated in
Figure 5 Effects of autophagic stimulation on ChikV infection. (A) HEK.293 cells were pretreated with the inducer of autophagy Rapamycin
(Rapa) (1 μM) for 2 hours before challenge with ChikV (MOI = 1) or left untreated (Ct). Infected cells were detected by immunofluorescence
detection of E1 glycoprotein. Nuclei were stained with DAPI. Magnification = 200× (B) Quantitative analysis of ChikV infected cells in cultures
maintained in the presence of medium alone (Ct) or supplemented with Rapamycin (Rapa). (C) Cultures analyzed in (B) were subjected to
qRT-PCR quantification of viral RNA present in cell culture supernatant. (D). Expression levels of ChikV structural proteins in HEK.293 infected cells
maintained in the presence or absence of Rapamycin was determined by Western blot analysis. Results are expressed as mean values of three
independent experiments +/- standard deviations.
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moting role for the replication of some viruses. Indeed,
the autophagic vesicles are thought to be used as scaffold
for intracellular membrane-associated replication factories
of RNA viruses [25]. This has been described for corona-
viruses, picornaviruses, murine hepatitis virus, equine
arterivirus, coxsackievirus and dengue virus [12-15].
The present study explores the role of the autophagic
machinery in ChikV-infected cells by monitoring the
presence of double-membrane vesicles and the distribu-
tion of LC3. We demonstrate the effects of perturbing
the autophagy pathway using pharmacological drugs or
RNA interference on viral replication. Using these stra-
tegies, we provide the first evidence that cellular autop-
hagy is promoted in ChikV-infected cells and that this
process enhances ChikV replication.
To understand whether autophagy plays a role in
ChikV infection, we assessed the localization of a GFP-
LC3 marker in uninfected or ChikV-infected HEK.293
cells by fluorescence microscopy experiments. ChikV
infection triggered an increase both in the number of
autophagic cells and in the number of GFP-LC3 dots per
cell. Of note, accumulation of autophagosomes can be du
to an increase in the autophagosomes formation or a
decrease of their degradation, which results to the block-
ade of the fusion with lysosomes. The early induction of
autophagy, within 2 hours post infection, is in favour of
the first hypothesis, nevertheless we can not exclude that
ChikV could also have a role in the late phases of autop-
hagosomes maturation. In the present study, we did not
answer this question, which remains to be elucidated.
To confirm our results, we performed an ultrastruc-
ture analysis by Transmission Electronic Microscopy
a n dv i s u a l i z e di nt h ec y t o p l a s mo fC h i k V - i n f e c t e dc e l l s
numerous vacuoles with features of autophagosomes.
Furthermore, virions are localized in the lumen of those
structures, consistent with the hypothesis that ChikV
may recruit autophagosomes into virus factories to gen-
erate a scaffold for replication complex. This hypothesis
need to be further investigated. The next step of the
study was to investigate the impact of the autophagic
process triggering in ChikV replication. For this pur-
pose, we blocked the autophagic process by two ways: a
pharmacological inhibition, using a common inhibitor,
3-Methyladenine, and a genetic inhibition, using RNA
interference against the transcript of the protein Beclin
1. We identified that ChikV replication is dramatically
decreased by both approaches, attesting that the autop-
hagic machinery is needed for ChikV replication. Both
the intracellular infection and extracellular RNA viral
load were assessed and were found to be affected, sug-
gesting that the autophagic machinery is needed to pro-
mote virus replication inside the cell and not only for
the release of new ChikV progeny virions outside the
cell. Of note, the partial blockade of both infection and
replication suggests that autophagy contributes but is
not strictly necessary for ChikV replication. We next
used an autophagic inducer, Rapamycin, to decipher the
impact of a stimulation of the autophagic process on
ChikV replication. After treatment with Rapamycin,
cells were much more permissive or sensitive to ChikV
infection, suggesting that autophagy is a promoting fac-
tor for ChikV replication.
Our previous study provided evidence that completion
of the apoptotic process is an important element for
efficient virus propagation [18]. Furthermore, ChikV-
induced apoptosis possibly leads to the persistence of
the virus in macrophages, and hence shielded from the
immune system. On the way to decipher the mechan-
isms either controlling viral infection or, on the con-
trary, promoting viral spreading and pathogenicity, it
seems that this virus has evolved to control both the
apoptotic and the autophagic process. ChikV seems to
be more than opportunistic and can exploit the classic
cellular immune response. From a therapeutic stand-
point, available drugs controlling autophagy could be
used to limit ChikV spreading.
Nonstandard abbreviations
ChikV: Chikungunya Virus; LC3: light chain 3; GFP-
LC3: LC3 fused to GFP; 3-MA: 3-methyladenine; Rapa:
Rapamycin.
Acknowledgements
We thank M. Biard-Piechaczyk for providing the GFP-LC3 construct. We thank
L. Espert and M. Biard-Piechaczyk for helpful scientific discussion. We thank
Maxime Solignat for skilful technical assistance in preliminary experiments.
Financial support was provided by INSERM ‘contrat d’interface to PG’, and
lab funding from CPER/FEDER, MOM, ANR (ANR-06-MIME-040-01). This work
was funded by the program ‘pathoviro’ of CRVOI (Centre de Recherche et
de Veille dans l’Océan Indien).
Author details
1IRG, EA 4517, Immunopathology and Infection Research Grouping, CHR
North Felix Guyon and University of La Reunion, St Denis, Ile de la Reunion,
France.
2Centre d’études d’agents Pathogènes et Biotechnologies pour la
Santé, CPBS - UMR 5236/CNRS - UM1/UM2, Montpellier, France.
3Microbiology/Virology Laboratory CHR North Felix Guyon, St Denis, Ile de la
Reunion, France.
Authors’ contributions
MD designed research; MD, GLPY, PKT, BG and JJH performed research; MD,
LB and PG and MCJB analysed data; MD wrote the paper. All authors read
and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 6 June 2011 Accepted: 8 September 2011
Published: 8 September 2011
References
1. Lumsden WH: An epidemic of virus disease in Southern Province,
Tanganyika Territory, in 1952-53. II. General description and
epidemiology. Trans R Soc Trop Med Hyg 1955, 49(1):33-57.
Krejbich-Trotot et al. Virology Journal 2011, 8:432
http://www.virologyj.com/content/8/1/432
Page 9 of 102. Miller S, Krijnse-Locker J: Modification of intracellular membrane
structures for virus replication. Nat Rev Microbiol 2008, 6(5):363-374.
3. Yoshimori T: Autophagy: a regulated bulk degradation process inside
cells. Biochem Biophys Res Commun 2004, 313(2):453-458.
4. Klionsky DJ: Autophagy: from phenomenology to molecular
understanding in less than a decade. Nat Rev Mol Cell Biol 2007,
8(11):931-937.
5. Klionsky DJ, Cregg JM, et al: A unified nomenclature for yeast autophagy-
related genes. Dev Cell 2003, 5(4):539-545.
6. Mizushima N, Ohsumi Y, et al: Autophagosome formation in mammalian
cells. Cell Struct Funct 2002, 27(6):421-429.
7. Levine B: Autophagy in development, tumor suppression, and innate
immunity. Harvey Lect 2003, 99:47-76.
8. Schmid D, Munz C: Innate and adaptive immunity through autophagy.
Immunity 2007, 27(1):11-21.
9. Liang XH, Kleeman LK, et al: Protection against fatal Sindbis virus
encephalitis by beclin, a novel Bcl-2-interacting protein. J Virol 1998,
72(11):8586-8596.
10. Liu Y, Schiff M, et al: Autophagy regulates programmed cell death during
the plant innate immune response. Cell 2005, 121(4):567-577.
11. Nakashima A, Tanaka N, et al: Survival of parvovirus B19-infected cells by
cellular autophagy. Virology 2006, 349(2):254-263.
12. Prentice E, Jerome WG, et al: Coronavirus replication complex formation
utilizes components of cellular autophagy. J Biol Chem 2004,
279(11):10136-10141.
13. Jackson WT, Giddings TH Jr, et al: Subversion of cellular autophagosomal
machinery by RNA viruses. PLoS Biol 2005, 3(5):e156.
14. Lee YR, Lei HY, et al: Autophagic machinery activated by dengue virus
enhances virus replication. Virology 2008, 374(2):240-248.
15. Wong J, Zhang J, et al: Autophagosome supports coxsackievirus B3
replication in host cells. J Virol 2008, 82(18):9143-9153.
16. Rodriguez-Rocha H, Gomez-Gutierrez JG, et al: Adenoviruses induce
autophagy to promote virus replication and oncolysis. Virology 2011,
416(1-2):9-15.
17. Hoarau JJ, Jaffar Bandjee MC, et al: Persistent chronic inflammation and
infection by Chikungunya arthritogenic alphavirus in spite of a robust
host immune response. J Immunol 2010, 184(10):5914-5927.
18. Krejbich-Trotot P, Denizot M, et al: Chikungunya virus mobilizes the
apoptotic machinery to invade host cell defenses. FASEB J 2011,
25(1):314-325.
19. Brun S, Solignat M, et al: VSV-G pseudotyping rescues HIV-1 CA mutations
that impair core assembly or stability. Retrovirology 2008, 5:57.
20. Solignat M, Gay B, et al: Replication cycle of chikungunya: a re-emerging
arbovirus. Virology 2009, 393(2):183-97.
21. Bernard E, Solignat M, et al: Endocytosis of chikungunya virus into
mammalian cells: role of clathrin and early endosomal compartments.
PLoS One 2010, 5(7).
22. Kabeya Y, Mizushima N, et al: LC3, a mammalian homologue of yeast
Apg8p, is localized in autophagosome membranes after processing.
EMBO J 2000, 19(21):5720-5728.
23. Seglen PO, Gordon PB: 3-Methyladenine: specific inhibitor of autophagic/
lysosomal protein degradation in isolated rat hepatocytes. Proc Natl Acad
Sci USA 1982, 79(6):1889-1892.
24. Orvedahl A, Alexander D, et al: HSV-1 ICP34.5 confers neurovirulence by
targeting the Beclin 1 autophagy protein. Cell Host Microbe 2007,
1(1):23-35.
25. Wileman T: Aggresomes and autophagy generate sites for virus
replication. Science 2006, 312(5775):875-878.
doi:10.1186/1743-422X-8-432
Cite this article as: Krejbich-Trotot et al.: Chikungunya triggers an
autophagic process which promotes viral replication. Virology Journal
2011 8:432.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Krejbich-Trotot et al. Virology Journal 2011, 8:432
http://www.virologyj.com/content/8/1/432
Page 10 of 10